Low income and education levels may cause medication overuse and chronicity in migraine patients

Headache

Volumn 45, Issue 1, 2005, Pages 25-31

  Atasoy, Huseyin Tugrul ^a   Unal, Aysun Eroglu ^a   Atasoy, Nuray ^a   Emre, Ufuk ^a   Sumer, Murat ^a  

^a ZONGULDAK KARAELMAS UNIVERSITY   (Turkey)

Author keywords

Education; Income; Medication overuse headache; Migraine

Indexed keywords

ARTICLE; CORRELATION ANALYSIS; DRUG INDUCED HEADACHE; HEALTH EDUCATION; HUMAN; LOGISTIC REGRESSION ANALYSIS; LOWEST INCOME GROUP; MAJOR CLINICAL STUDY; MIGRAINE; PRIORITY JOURNAL; RISK; SOCIAL STATUS; SOCIOECONOMICS; STATISTICAL ANALYSIS;

ADULT; AGED; ANALGESICS; CHRONIC DISEASE; EDUCATIONAL STATUS; FEMALE; HEADACHE DISORDERS; HUMANS; INCOME; MALE; MIDDLE AGED; MIGRAINE DISORDERS; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 11844298937     PISSN: 00178748     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1526-4610.2005.05006.x     Document Type: Article

References (38)

1. Castillo J, Munoz P, Guitera V, Pascual J. Epidemiology of chronic daily headache in general population. Headache. 1999;39:190-196.
2. Scher AI, Stewart WF, Liberman J, Lipton RB. Prevalance of frequent headache in a population sample. Headache. 1998;38:497-506.
3. Mathew NT. Chronic refractory headache. Neurology. 1993;43:S26-S33.
4. Silberstein SD. Drug-induced headache. Neurol Clin. 1998;16:107-23.
5. Colas R, Munoz P, Temprano R, Gomez C, Pascual J. Chronic daily headache with analgesic overuse: epidemiology and impact on quality of life. Neurology. 2004;62:1338-1342.
6. Mathew NT, Reuveni U, Perez F. Transformed or evolutive migraine. Headache. 1987;27:102-106.
7. Pini LA, Cicero AF, Sandrini M. Long-term follow-up of patients treated for chronic headache with analgesic overuse. Cephalalgia. 2001;21:878-883.
8. Suhr B, Evers S, Bauer B, Gralow J, Grotemeyer KH, Husstedt IW. Drug-induced headache: long-term results of stationary versus ambulatory withdrawal therapy. Cephalalgia. 1999;19:44-49.
9. Tribl GG, Schnider P, Wober C, et al. Are there predictive factors for long-term outcome after withdrawal in drug-induced chronic daily headache? Cephalalgia. 2001;21:691-696.
10. Srikiatkhachorn A, Phanthumchinda K. Prevalence and clinical features of chronic daily headache in a headache clinic. Headache. 1997;37:277-280.
11. Fusco BM, Colantoni O, Giacovazzo M. Alteration of central excitation circuits in chronic headache and analgesic misuse. Headache. 1997;37:486-491.
12. Sarchielli P, Alberti A, Floridi A, Gallai V. Levels of nerve growth factor in cerebrospinal fluid of chronic daily headache patients. Neurology. 2001;57:132-134.
13. Schnider P, Maly J, Mraz M, Brantner-Inthaler S, Zeiler K, Wessely P. MMPI and critical flicker frequency (CFF) analysis in headache patients with and without drug abuse. Headache. 1995;35:17-20.
14. Siniatchkin M, Gerber WD, Kropp P, Vein A. Contingent negative variation in patients with chronic daily headache. Cephalalgia. 1998;18:565-569.
15. Sandrini M, Vitale G, Pini LA, Sternieri E, Bertolini A. Effects of chronic treatment with phenazone on the hot hot-plate test and serotonin binding sites in pons and cortex membranes of the rat. Pharmacology. 1993;47:84-90.
16. Srikiatkhachorn A, Tarasub N, Govitrapong P. Effect of chronic analgesic exposure on the central serotonin system: a possible mechanism of analgesic abuse headache. Headache. 2000;40:343-350.
17. Breslau N, Davis GC, Andreski P. Migraine, psychiatric disorders, and suicide attempts: an epidemiologic study of young adults. Psychiatr Res. 1991;37:11-23.
18. Lipton RB, Stewart WF, Scher AI. Epidemiology and economic impact of migraine. Curr Med Res Opin. 2001;17:4-12.
19. Stang P, Sternfeld B, Sidney S. Migraine headache in a prepaid health plan: ascertainment, demographics, physiological, and behavioral factors. Headache. 1996;36:69-16.
20. Hagen K, Vatten L, Stovner LJ, Zwart JA, Krokstad S, Bovim G. Low socio-economic status associated with increased risk of frequent headache: a prospective study of 22718 adults in Norway. Cephalalgia. 2002;22:672-679.
21. Stewart WF, Lipton RB, Celentano DD, Reed ML. Prevalance of migraine headache in the United States. Relation to age, income, race, and other sociodemographic factors. JAMA. 1992;267:64-69.
22. Hasvold T, Johnsen R, Forde OH. Non-migrainous headache, neck or shoulder pain, and migraine-differences in association with background factors in a city population. Scand J Prim Health Care. 1996;14:92-99.
23. Launer LJ, Terwindt GM, Ferrari MD. The prevalence and characteristics of migraine in a population-based cohort: the GEM study. Neurology. 1999;53:537-543.
24. Merikangas KR, Angst J, Isler H. Migraine and psychopathology. Arch Gen Psychiatry. 1990;47:849-853.
25. Rasmussen BK. Migraine and tension-type headache in a general population: psychosocial factors. Int J Epidemiol. 1992;21:1138-1143.
26. Breslau N, Schultz LR, Stewart WF, Lipton RB, Lucia VC, Welch KMA. Headache and major depression: is the association specific to migraine? Neurology. 2000;54:308-313.
27. Breslau N, Schultz LR, Stewart WF, Lipton RB, Welch KMA. Headache types and panic disorder directionality and specificity. Neurology. 2001;56:350-354.
28. Juang KD, Wang SJ, Fuh JL, Lu SR, Su TP. Comorbidity of depressive and anxiety disorders in chronic daily headache and its subtypes. Headache. 2000;40:818-823.
29. Mitsikostas DD, Thomas AM. Comorbidity of headache and depressive disorders. Cephalalgia. 1999;19:211-217.
30. Headache Classification Committee of the International Headache Society. The International Classification of Headache Disorders, 2nd edition. Cephalalgia. 2004;24:1-151.
31. First MB, Spitzer RL, Gibbon M, Williams J. Structured Clinical Interview for DSMIV Axis I Disorders (SCID-I), Clinical Version. Washington, DC: American Psychiatric Press; 1997.
32. Antonov K, Isacson D. Headache and analgesic use in Sweden. Headache. 1998;38:97-104.
33. Evers S, Suhr B, Bauer B, Grotemeyer KH, Husstedt IW. A retrospective long-term analysis of the epidemiology and features of drug-induced headache. J Neurol. 1999;246:802-809.
34. Fritsche G, Eberl A, Katsavara Z, Limmroth V, Diener HC. Drug-induced headache: long-term follow-up of withdrawal therapy and persistence of drug misuse. Eur Neurol. 2001;45:229-235.
35. Baumgartner C, Wessely P, Bingöl C, Maly J, Holzner F. Longterm prognosis analgesic withdrawal in patients with drug-induced headaches. Headache. 1989;29:510-514.
36. Silberstein SD, Silberstein JR. Chronic daily headache: long-term prognosis following inpatient treatment with repetitive IV DHE. Headache. 1992;32:439-445.
37. Silberstein SD. Tension-type and chronic daily headache. Neurology. 1993;43:1644-1649
38. Radat F, Sakh D, Lutz G, El Amrani M, Ferreri M, Bousser MG. Psychiatric comorbidity is related to headache induced by chronic substance use in migraineurs. Headache. 1999;39:477-480.